D
Devyser Diagnostics AB
F:OL0
Devyser Diagnostics AB
F:OL0
Price:
9.7
EUR
0.52%
Market Closed
Market Cap:
€156.8m
Cash Flow Statement
Cash Flow Statement
Devyser Diagnostics AB
Devyser Diagnostics AB
Currency: SEK
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(27)
|
(40)
|
(40)
|
(52)
|
(66)
|
(67)
|
(66)
|
(59)
|
(52)
|
(62)
|
(78)
|
(58)
|
(67)
|
(32)
|
(7)
|
|
| Depreciation & Amortization |
6
|
8
|
8
|
9
|
10
|
10
|
11
|
13
|
17
|
21
|
24
|
28
|
28
|
28
|
28
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
7
|
8
|
9
|
9
|
14
|
13
|
14
|
12
|
|
| Cash Interest Paid |
1
|
2
|
1
|
1
|
1
|
0
|
(0)
|
1
|
2
|
2
|
3
|
4
|
3
|
3
|
3
|
|
| Change in Working Capital |
(9)
|
(6)
|
(2)
|
2
|
3
|
(12)
|
(16)
|
(31)
|
(40)
|
(29)
|
(15)
|
(30)
|
(15)
|
(26)
|
(37)
|
|
| Cash from Operating Activities |
(29)
N/A
|
(37)
-27%
|
(33)
+11%
|
(41)
-23%
|
(52)
-29%
|
(67)
-28%
|
(69)
-3%
|
(70)
0%
|
(67)
+4%
|
(60)
+11%
|
(59)
+2%
|
(47)
+20%
|
(42)
+10%
|
(18)
+56%
|
(6)
+70%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(14)
|
(19)
|
(20)
|
(26)
|
(26)
|
(35)
|
(31)
|
(32)
|
(53)
|
(50)
|
(65)
|
(77)
|
(69)
|
(76)
|
(77)
|
|
| Other Items |
0
|
0
|
2
|
2
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
|
| Cash from Investing Activities |
(14)
N/A
|
(18)
-33%
|
(19)
-2%
|
(24)
-29%
|
(26)
-10%
|
(35)
-32%
|
(31)
+11%
|
(32)
-3%
|
(53)
-65%
|
(50)
+5%
|
(65)
-29%
|
(77)
-19%
|
(70)
+9%
|
(77)
-10%
|
(77)
0%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
355
|
356
|
353
|
55
|
6
|
6
|
10
|
6
|
6
|
21
|
20
|
24
|
23
|
11
|
13
|
|
| Net Issuance of Debt |
(2)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(9)
|
(12)
|
(14)
|
(16)
|
(15)
|
(14)
|
(13)
|
|
| Other |
(23)
|
(23)
|
(23)
|
(3)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
330
N/A
|
329
0%
|
327
-1%
|
49
-85%
|
1
-97%
|
2
+14%
|
5
+195%
|
(0)
N/A
|
(3)
-1 300%
|
10
N/A
|
6
-39%
|
8
+30%
|
8
+4%
|
(4)
N/A
|
0
N/A
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
1
|
1
|
1
|
2
|
3
|
1
|
1
|
0
|
(1)
|
2
|
(3)
|
2
|
(2)
|
(5)
|
|
| Net Change in Cash |
287
N/A
|
275
-4%
|
276
+1%
|
(14)
N/A
|
(76)
-440%
|
(98)
-29%
|
(94)
+4%
|
(101)
-7%
|
(122)
-21%
|
(101)
+17%
|
(116)
-14%
|
(118)
-2%
|
(101)
+15%
|
(102)
0%
|
(87)
+14%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(43)
N/A
|
(55)
-29%
|
(53)
+4%
|
(66)
-24%
|
(79)
-19%
|
(102)
-30%
|
(100)
+2%
|
(102)
-1%
|
(120)
-18%
|
(110)
+8%
|
(123)
-12%
|
(124)
0%
|
(111)
+10%
|
(95)
+15%
|
(82)
+13%
|
|
Switch to:
Switch to:
See Also
Discover More
